Active ingredients from natural and biotech sources to hydrate, reduce fine lines, balance skin tone, fade pigmentation.

SKIN TREATMENTS

CUSTOMISIED PEELS

ABOUT

Our peels contain the highest concentrations of chirally correct, active ingredients, using both all-natural, organic resources and high-performance compounds sourced from the most advanced biotech and pharmaceutical companies in the world.enjoy firmer, youthful skin with a healthy glow!

Downtime 1 - 2 days
Pain ●○○○○
Treatment Time 30 minutes

RESULTS

Intensely hydrate your skin
Reduce the appearance of fine lines and wrinkles
Balance your skin tone and fade pigmentation
Control acne and create a smooth texture

TREATMENT PREPARATION

All skins must be primed on the minimum of an Aspect™ Basic Starter Kit (Purastat 5, Exfol L15, Extreme C20 and Phytostat 9) with Sun Protection for between 2 to 4 weeks ideally prior to a peel:

To get the most effective even depth
To achieve the best results
To reduce the risk of unnecessary inflammation, maceration or blanching

Note: Regimes may vary depending on skin condition. E.g. Brightening Kit for Hyperpigmentation or Problem Skin Kit for Problematic skin

Note: 20% Lactobotanical is the exception for resilient skin types

HOW IT WORKS

The Aspect™ Lactobotanical peel series is a powerful yet gentle and potentially superior alternative to traditional Glycolic Acid peels. The Lactobotanical Peel series is exclusively available to paramedical and medically affiliated practices.

Lactobotanical formulas are a synergistic marriage between chirally correct L- Lactic Acid and the patented Canadian Willowherb™ extract.

Available in 20%, 30% and 40% concentration pH 2.9 - 3.15

WHAT TO EXPECT

Variable, ranging from no visible peeling to a light to moderate flaking of skin between days 2-7 after the peel.
Increase in breakout may be expected with initial treatments and indicates positive progress.
Skin may appear flushed and feel tight for several days, and discolorations may temporarily darken before peeling away.

WHO IS NOT SUITABLE

Patients at risk of post inflammatory hyper-pigmentation and for Fitzpatrick III-VI.